Literature DB >> 23317264

Hypertension and the risk of breast cancer in Chilean women: a case-control study.

Ana Pereira1, Maria Luisa Garmendia, Maria Elena Alvarado, Cecilia Albala.   

Abstract

BACKGROUND: Breast cancer is the most common cancer in women worldwide. Although different metabolic factors have been implicated in breast cancer development, the relationship between hypertension and breast cancer has not been elucidated. AIM: To evaluate hypertension as a risk factor for breast cancer in Chilean women of low and middle socio-economic status.
METHODS: We conducted an age-matched (1:1) case-control study in 3 hospitals in Santiago, Chile. Breast cancer cases (n=170) were histopathologically confirmed. Controls had been classified as Breast Imaging Reporting and Data System I (negative) or II (benign findings) within 6 months of recruitment. Blood pressure was measured using a mercury sphygmomanometer and standardized procedures. We used 2 hypertension cut-off points: blood pressures of ≥140/90 mmHg and ≥130/85 mmHg. Fasting insulin and glucose levels were assessed, and anthropometric, sociodemographic, and behavioral information were collected. Odds ratios and 95% confidence intervals were estimated for the entire sample and restricted to postmenopausal women using multivariable conditional logistic regression models.
RESULTS: Hypertension (≥140/90 mmHg) was significantly higher in cases (37.1%) than controls (17.1%) for the entire sample and in postmenopausal pairs (44.0% compared to 23.8%). In crude and adjusted models, hypertensive women had a 4-fold increased risk of breast cancer (adjusted odds ratio: 4.2; 95% confidence interval: 1.8; 9.6) compared to non-hypertensive women in the entire sample. We found a similar association in the postmenopausal group (adjusted odds ratio: 2.8; 95% confidence interval: 1.1; 7.4). A significant effect was also observed when hypertension was defined as blood pressure of ≥130/85 mmHg.
CONCLUSION: A significant association was found between hypertension and breast cancer over the entire sample and when restricted to postmenopausal women. Hypertension is highly prevalent in Latin America and may be a modifiable risk factor for breast cancer; therefore, a small association between hypertension and breast cancer may have broad implications.

Entities:  

Mesh:

Year:  2012        PMID: 23317264     DOI: 10.7314/apjcp.2012.13.11.5829

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  11 in total

1.  Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype.

Authors:  Daniel T Dibaba; Kemi Ogunsina; Dejana Braithwaite; Tomi Akinyemiju
Journal:  Breast Cancer Res Treat       Date:  2018-11-21       Impact factor: 4.872

Review 2.  Association of Hypertension and Organ-Specific Cancer: A Meta-Analysis.

Authors:  Morgan Connaughton; Mahsa Dabagh
Journal:  Healthcare (Basel)       Date:  2022-06-09

3.  The Hypertension Related Gene G-Protein Coupled Receptor Kinase 4 Contributes to Breast Cancer Proliferation.

Authors:  Wei Yue; Hanh T Tran; Ji-Ping Wang; Katherine Schiermeyer; John J Gildea; Peng Xu; Robin A Felder
Journal:  Breast Cancer (Auckl)       Date:  2021-05-20

4.  Hypertension and subsequent genitourinary and gynecologic cancers risk: a population-based cohort study.

Authors:  Li-Min Sun; Huang-Tsung Kuo; Long-Bin Jeng; Cheng-Li Lin; Ji-An Liang; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

Review 5.  Hypertension and breast cancer risk: a systematic review and meta-analysis.

Authors:  Hedong Han; Wei Guo; Wentao Shi; Yamei Yu; Yunshuo Zhang; Xiaofei Ye; Jia He
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

Review 6.  Cancer and comorbidity: The role of leptin in breast cancer and associated pathologies.

Authors:  Amitabha Ray
Journal:  World J Clin Cases       Date:  2018-10-26       Impact factor: 1.337

Review 7.  Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis.

Authors:  Shuwen Dong; Zheng Wang; Kunwei Shen; Xiaosong Chen
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244

Review 8.  A narrative review on the interaction between genes and the treatment of hypertension and breast cancer.

Authors:  Wenjuan Wang; Qingjian He; Haodong Zhang; Chenchen Zhuang; Qiongying Wang; Caie Li; Runmin Sun; Xin Fan; Jing Yu
Journal:  Ann Transl Med       Date:  2021-05

9.  Metabolic Syndrome and the Risk of Breast Cancer and Subtypes by Race, Menopause and BMI.

Authors:  Daniel T Dibaba; Dejana Braithwaite; Tomi Akinyemiju
Journal:  Cancers (Basel)       Date:  2018-09-01       Impact factor: 6.639

10.  Metabolic dysregulation and cancer mortality in a national cohort of blacks and whites.

Authors:  Tomi Akinyemiju; Justin Xavier Moore; Suzanne Judd; Susan Lakoski; Michael Goodman; Monika M Safford; Maria Pisu
Journal:  BMC Cancer       Date:  2017-12-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.